Weekly Cisplatin or Nedaplatin Concurrent With Intensity-modulated Radiation Therapy in Nasopharyngeal Carcinoma
Status:
Unknown status
Trial end date:
1969-12-31
Target enrollment:
Participant gender:
Summary
This is a randomized Phase III study to evaluate efficancy of weekly cisplatin or nedaplatin
concurrent with Intensity-modulated radiation therapy in Nasopharyngeal Carcinoma (NPC).